| # | % | |||||
|---|---|---|---|---|---|---|
| 1 | MEDIVATION INC | 4,397,838 | 202,213,000 | 82.11% | ||
| 2 | SYNTHETIC BIOLOGICS INC | 3,734,149 | 8,813,000 | 3.58% | ||
| 3 | AMPIO PHARMACEUTICALS INC | 3,388,322 | 7,624,000 | 3.10% | ||
| 4 | CORBUS PHARMACEUTICALS HLDGS COM | 2,563,925 | 4,641,000 | 1.88% | ||
| 5 | ALCOBRA LTD | 1,115,315 | 4,227,000 | 1.72% | ||
| 6 | ABEONA THERAPEUTICS INC | 1,359,767 | 3,481,000 | 1.41% | ||
| 7 | CEMPRA INC | 180,800 | 3,168,000 | 1.29% | ||
| 8 | Advaxis Inc. | 275,000 | 2,483,000 | 1.01% | ||
| 9 | NEWLINK GENETICS CORP | 102,437 | 1,864,000 | 0.76% | ||
| 10 | VOLITIONRX LTD | 461,538 | 1,638,000 | 0.67% | ||
| 11 | Vascular Biologics LTD | 333,332 | 1,160,000 | 0.47% | ||
| 12 | KERYX BIOPHARMACEUTICALS INCORPORATED | 200,000 | 934,000 | 0.38% | ||
| 13 | Advaxis Inc. | 112,500 | 677,000 | 0.27% | ||
| 14 | OHR PHARMACEUTICAL INC | 205,000 | 658,000 | 0.27% | ||
| 15 | BIOBLAST PHARMA LTD | 250,970 | 625,000 | 0.25% | ||
| 16 | ALDEYRA THERAPEUTICS INC | 135,800 | 569,000 | 0.23% | ||
| 17 | Caladrius Biosciences Inc | 555,781 | 417,000 | 0.17% | ||
| 18 | CHAMPIONS ONCOLOGY INC | 111,111 | 405,000 | 0.16% | ||
| 19 | Galmed Pharmaceuticals Ltd | 65,000 | 320,000 | 0.13% | ||
| 20 | Evoke Pharma Inc | 55,660 | 283,000 | 0.11% | ||
| 21 | Zosano Pharma Corp | 18,600 | 43,000 | 0.02% | ||
| 22 | Aptose Biosciences Inc Com New | 11,933 | 34,000 | 0.01% |
Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0001144204-16-102574, filed 2016.05.16).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
